EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report

Gioia Di Stefano, Vieri Grandi, Virginia Alba Colantuono, Chiara Frattini, Benedetta Peruzzi, Roberto Caporale, Nicola Pimpinelli, Raffaella Santi

Frontiers in Oncology · 27.07.2026 · 16

DOI: 10.3389/fonc.2026.1890945 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 27.07.2026. Verfasst von Gioia Di Stefano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycosis fungoides (MF) shows a broad clinical spectrum, ranging from indolent disease to aggressive variants with poor outcomes. T Follicular Helper (TFH) marker expression has been reported in a subset of MF, with uncertain prognostic significance, while GATA3 has emerged as a potential adverse prognostic marker in MF and nodal T-cell lymphomas. Herein, we report a case of MF investigated through sequential histopathological and phenotypic analyses, including extended TFH markers and GATA3 immunohistochemistry. Initially diagnosed as conventional MF, the disease evolved after 3 years into MF with large cell transformation and leukemic involvement, characterized by prominent folliculotropism, a TFH phenotype, and diffuse GATA3 expression. Retrospective analysis of the initial biopsy identified a minor TFH/GATA3-positive neoplastic population (10%) already present at onset, supporting a model of progressive phenotypic plasticity evolving over time. This case underscores the biological heterogeneity of MF, suggesting that a TFH phenotype and GATA3 expression may help identify patients with a more aggressive disease course, potentially amenable to mogamulizumab-based targeted immunotherapy. Incorporating extended TFH markers and GATA3 into routine immunohistochemical assessment could refine risk stratification and inform treatment decisions.

Schlagwörter

Stichwörter der Autor:innen

GATA3Sezary syndromeT follicular helperfolliculotropismmycosis fungoidesprimary cutaneous T-cell lymphomas

Autor:innen und Institutionen

  • Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
  • Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Flow Cytometry and Immunology Diagnostic Unit, Careggi University Hospital, Florence, Italy.
  • Pathology Section, Department of Health Sciences, University of Florence, Florence, Italy.

Zitieren

APA

Di Stefano, G., Grandi, V., Colantuono, V. A., Frattini, C., Peruzzi, B., Caporale, R., Pimpinelli, N., & Santi, R. (2026). GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1890945

Vancouver

Di Stefano G, Grandi V, Colantuono VA, Frattini C, Peruzzi B, Caporale R, et al. GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1890945

BibTeX
@article{DiStefano2026,
  author = {Di Stefano, Gioia and Grandi, Vieri and Colantuono, Virginia Alba and Frattini, Chiara and Peruzzi, Benedetta and Caporale, Roberto and Pimpinelli, Nicola and Santi, Raffaella},
  title = {GATA3-positivity and T follicular helper phenotype in transformed mycosis fungoides with leukemic involvement and prominent folliculotropism: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1890945}
}
Kostenlos starten →